The American Lawyer: Deal Watch: M&A Deal Value Down 38% Last Year, as Hopes Fade for Quick Rebound

1月 03, 2023

O’Melveny represented OrbusNeich Medical Group Holdings Limited, a global medical device manufacture, in its approximate US$62 million initial public offering and listing of ordinary shares on the Main Board of the Hong Kong Stock Exchange. The O’Melveny team, which advised the company on Hong Kong and US law, was led by partners Edwin Kwok and Vincent Lin.

Read the full article here.